CIK 0001856725
- Emerging growth company
Rani Therapeutics Holdings, Inc.
Sign in to watch- Ticker
- RANI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 863114789
- Phone
- +1 408-457-3700
- Business address
- 47709 FREMONT BLVD, FREMONT, CA, 94538
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 5,255 shares at an average $3.92 ($20,626)
- 4 Open-market buy 10% owner bought 4,420 shares at $4.46 ($19,733)
- 4 Open-market buy 10% owner bought 2,040 shares at $4.81 ($9,816)
- 4 Open-market buy 10% owner bought 2,173 shares at $4.71 ($10,225)
- 4 Open-market buy 10% owner bought 8,703 shares at an average $4.59 ($39,947)
- 4 Open-market buy 10% owner bought 5,950 shares at an average $5.05 ($30,074)
- 4 Open-market buy 10% owner bought 1,850 shares at $5.37 ($9,939)
- 4 Open-market buy 10% owner bought 1,901 shares at $5.27 ($10,019)
- 4 Open-market buy 10% owner bought 4,467 shares at an average $5.47 ($24,449)
- 4 Open-market buy 10% owner bought 3,688 shares at an average $5.31 ($19,590)
- 4 Open-market buy 10% owner bought 7,551 shares at $5.14 ($38,775)
- 4 Open-market buy 10% owner bought 11,696 shares at an average $5.49 ($64,192)
Page 5 of 10 · 194 filings